| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | mannosyl-oligosaccharide 1,3-1,6-alpha-mannosidase activity | 1.51e-05 | 2 | 78 | 2 | GO:0004572 | |
| Domain | ZnF_C2HC | 2.20e-09 | 55 | 75 | 7 | SM00343 | |
| Domain | Znf_CCHC | 2.20e-09 | 55 | 75 | 7 | IPR001878 | |
| Domain | ZINC_FINGER_C2H2_2 | ZXDC ZNF536 VEZF1 ZNF425 ZSCAN5A FIZ1 PLAG1 ZNF217 TRMT1L ZNF565 ZNF319 ZNF865 ZNF786 | 1.15e-05 | 775 | 75 | 13 | PS50157 |
| Domain | ZINC_FINGER_C2H2_1 | ZXDC ZNF536 VEZF1 ZNF425 ZSCAN5A FIZ1 PLAG1 ZNF217 TRMT1L ZNF565 ZNF319 ZNF865 ZNF786 | 1.18e-05 | 777 | 75 | 13 | PS00028 |
| Domain | Znf_C2H2-like | ZXDC ZNF536 VEZF1 ZNF425 ZSCAN5A FIZ1 PLAG1 ZNF217 TRMT1L ZNF565 ZNF319 ZNF865 ZNF786 | 1.52e-05 | 796 | 75 | 13 | IPR015880 |
| Domain | - | ZXDC ZNF536 VEZF1 ZNF425 ZSCAN5A FIZ1 PLAG1 ZNF217 ZNF565 ZNF319 ZNF865 ZNF786 | 1.55e-05 | 679 | 75 | 12 | 3.30.160.60 |
| Domain | Znf_C2H2 | ZXDC ZNF536 VEZF1 ZNF425 ZSCAN5A FIZ1 PLAG1 ZNF217 TRMT1L ZNF565 ZNF319 ZNF865 ZNF786 | 1.71e-05 | 805 | 75 | 13 | IPR007087 |
| Domain | ZnF_C2H2 | ZXDC ZNF536 VEZF1 ZNF425 ZSCAN5A FIZ1 PLAG1 ZNF217 TRMT1L ZNF565 ZNF319 ZNF865 ZNF786 | 1.78e-05 | 808 | 75 | 13 | SM00355 |
| Domain | Znf_C2H2/integrase_DNA-bd | ZXDC ZNF536 VEZF1 ZNF425 ZSCAN5A FIZ1 PLAG1 ZNF217 ZNF565 ZNF319 ZNF865 ZNF786 | 1.92e-05 | 694 | 75 | 12 | IPR013087 |
| Domain | PLAC | 2.19e-05 | 14 | 75 | 3 | PF08686 | |
| Domain | PLAC | 5.75e-05 | 19 | 75 | 3 | PS50900 | |
| Domain | PLAC | 5.75e-05 | 19 | 75 | 3 | IPR010909 | |
| Domain | ADAM_spacer1 | 1.04e-04 | 23 | 75 | 3 | IPR010294 | |
| Domain | ADAM_spacer1 | 1.04e-04 | 23 | 75 | 3 | PF05986 | |
| Domain | Peptidase_M12B_ADAM-TS | 1.18e-04 | 24 | 75 | 3 | IPR013273 | |
| Domain | - | 1.58e-04 | 5 | 75 | 2 | 1.20.1270.50 | |
| Domain | - | 1.58e-04 | 5 | 75 | 2 | 3.20.110.10 | |
| Domain | Glyco_hydro_38_C | 1.58e-04 | 5 | 75 | 2 | IPR011682 | |
| Domain | Alpha-mann_mid | 1.58e-04 | 5 | 75 | 2 | SM00872 | |
| Domain | Alpha-mann_mid | 1.58e-04 | 5 | 75 | 2 | PF09261 | |
| Domain | Glyco_hydro_38_N | 1.58e-04 | 5 | 75 | 2 | IPR000602 | |
| Domain | Glyco_hydro_38/57_N | 1.58e-04 | 5 | 75 | 2 | IPR027291 | |
| Domain | Glyco_hydro_38_cen | 1.58e-04 | 5 | 75 | 2 | IPR015341 | |
| Domain | Glyco_hydro_57/38_cen | 1.58e-04 | 5 | 75 | 2 | IPR028995 | |
| Domain | Glyco_hydro_38C | 1.58e-04 | 5 | 75 | 2 | PF07748 | |
| Domain | Glyco_hydro_38 | 1.58e-04 | 5 | 75 | 2 | PF01074 | |
| Domain | RIH_assoc | 2.36e-04 | 6 | 75 | 2 | PF08454 | |
| Domain | RIH_assoc-dom | 2.36e-04 | 6 | 75 | 2 | IPR013662 | |
| Domain | RIH_dom | 2.36e-04 | 6 | 75 | 2 | IPR000699 | |
| Domain | Ins145_P3_rcpt | 2.36e-04 | 6 | 75 | 2 | IPR014821 | |
| Domain | Ryanodine_recept-rel | 2.36e-04 | 6 | 75 | 2 | IPR015925 | |
| Domain | - | 2.36e-04 | 6 | 75 | 2 | 1.25.10.30 | |
| Domain | RYDR_ITPR | 2.36e-04 | 6 | 75 | 2 | PF01365 | |
| Domain | Ins145_P3_rec | 2.36e-04 | 6 | 75 | 2 | PF08709 | |
| Domain | Glyco_hydro/deAcase_b/a-brl | 3.30e-04 | 7 | 75 | 2 | IPR011330 | |
| Domain | eIF5C | 3.30e-04 | 7 | 75 | 2 | SM00515 | |
| Domain | W2 | 3.30e-04 | 7 | 75 | 2 | PF02020 | |
| Domain | W2 | 3.30e-04 | 7 | 75 | 2 | PS51363 | |
| Domain | W2_domain | 3.30e-04 | 7 | 75 | 2 | IPR003307 | |
| Domain | zf-C2H2 | ZNF536 VEZF1 ZNF425 ZSCAN5A FIZ1 ZNF217 ZNF565 ZNF319 ZNF865 ZNF786 | 4.35e-04 | 693 | 75 | 10 | PF00096 |
| Domain | Peptidase_M12B_N | 5.12e-04 | 39 | 75 | 3 | IPR002870 | |
| Domain | Pep_M12B_propep | 5.12e-04 | 39 | 75 | 3 | PF01562 | |
| Domain | DISINTEGRIN_1 | 5.52e-04 | 40 | 75 | 3 | PS00427 | |
| Domain | Reprolysin | 5.52e-04 | 40 | 75 | 3 | PF01421 | |
| Domain | ADAM_MEPRO | 5.52e-04 | 40 | 75 | 3 | PS50215 | |
| Domain | DISINTEGRIN_2 | 5.52e-04 | 40 | 75 | 3 | PS50214 | |
| Domain | Peptidase_M12B | 5.52e-04 | 40 | 75 | 3 | IPR001590 | |
| Domain | EGF_1 | 5.60e-04 | 255 | 75 | 6 | PS00022 | |
| Domain | Disintegrin_dom | 5.94e-04 | 41 | 75 | 3 | IPR001762 | |
| Domain | EGF-like_CS | 6.32e-04 | 261 | 75 | 6 | IPR013032 | |
| Domain | EGF_2 | 6.85e-04 | 265 | 75 | 6 | PS01186 | |
| Domain | MIR | 7.01e-04 | 10 | 75 | 2 | PS50919 | |
| Domain | MIR | 7.01e-04 | 10 | 75 | 2 | PF02815 | |
| Domain | MIR | 7.01e-04 | 10 | 75 | 2 | SM00472 | |
| Domain | MIR_motif | 7.01e-04 | 10 | 75 | 2 | IPR016093 | |
| Domain | Laminin_G_1 | 8.55e-04 | 11 | 75 | 2 | PF00054 | |
| Domain | - | 1.40e-03 | 14 | 75 | 2 | 2.60.40.1180 | |
| Domain | Glyco_hydro_b | 1.62e-03 | 15 | 75 | 2 | IPR013780 | |
| Domain | MIF4-like | 1.62e-03 | 15 | 75 | 2 | IPR016021 | |
| Domain | - | 1.62e-03 | 15 | 75 | 2 | 1.25.40.180 | |
| Domain | Laminin_G | 1.64e-03 | 58 | 75 | 3 | IPR001791 | |
| Domain | EGF_extracell | 1.81e-03 | 60 | 75 | 3 | IPR013111 | |
| Domain | EGF_2 | 1.81e-03 | 60 | 75 | 3 | PF07974 | |
| Domain | TSP_1 | 2.08e-03 | 63 | 75 | 3 | PF00090 | |
| Domain | Gal_mutarotase_SF_dom | 2.08e-03 | 17 | 75 | 2 | IPR011013 | |
| Domain | TSP1 | 2.27e-03 | 65 | 75 | 3 | SM00209 | |
| Domain | TSP1_rpt | 2.27e-03 | 65 | 75 | 3 | IPR000884 | |
| Domain | TSP1 | 2.27e-03 | 65 | 75 | 3 | PS50092 | |
| Domain | EGF_3 | 2.55e-03 | 235 | 75 | 5 | PS50026 | |
| Domain | EGF-like_dom | 3.27e-03 | 249 | 75 | 5 | IPR000742 | |
| Pathway | WP_TGFBETA_RECEPTOR_SIGNALING_IN_SKELETAL_DYSPLASIAS | 5.09e-05 | 59 | 49 | 4 | M39886 | |
| Pubmed | FAM90A14 FAM90A17 FAM90A19 FAM90A22 FAM90A23 FAM90A2P FAM90A1 FAM90A7 FAM90A18 FAM90A9 FAM90A8 FAM90A16 FAM90A10 | 1.54e-28 | 25 | 83 | 13 | 17684299 | |
| Pubmed | FAM90A14 FAM90A17 FAM90A19 FAM90A22 FAM90A23 FAM90A2P FAM90A7 FAM90A9 FAM90A8 FAM90A16 FAM90A10 | 9.47e-24 | 23 | 83 | 11 | 18602769 | |
| Pubmed | Placental PPARγ regulates spatiotemporally diverse genes and a unique metabolic network. | FAM90A14 FAM90A17 FAM90A19 FAM90A22 FAM90A26 FAM90A23 FAM90A1 FAM90A7 FAM90A9 FAM90A8 FAM90A10 | 2.20e-13 | 164 | 83 | 11 | 22967998 |
| Pubmed | 5.63e-06 | 2 | 83 | 2 | 11279015 | ||
| Pubmed | 5.63e-06 | 2 | 83 | 2 | 24285081 | ||
| Pubmed | 5.63e-06 | 2 | 83 | 2 | 8524845 | ||
| Pubmed | 5.63e-06 | 2 | 83 | 2 | 18586264 | ||
| Pubmed | 5.63e-06 | 2 | 83 | 2 | 36394358 | ||
| Pubmed | 5.63e-06 | 2 | 83 | 2 | 21738216 | ||
| Pubmed | N-Glycan structure analysis using lectins and an alpha-mannosidase activity assay. | 5.63e-06 | 2 | 83 | 2 | 17113875 | |
| Pubmed | Germ cell survival through carbohydrate-mediated interaction with Sertoli cells. | 5.63e-06 | 2 | 83 | 2 | 11778047 | |
| Pubmed | 5.63e-06 | 2 | 83 | 2 | 16754854 | ||
| Pubmed | 1.24e-05 | 19 | 83 | 3 | 33422265 | ||
| Pubmed | 1.69e-05 | 3 | 83 | 2 | 11745332 | ||
| Pubmed | 1.69e-05 | 3 | 83 | 2 | 10648616 | ||
| Pubmed | 3.37e-05 | 4 | 83 | 2 | 16931570 | ||
| Pubmed | 3.37e-05 | 4 | 83 | 2 | 19578754 | ||
| Pubmed | 3.37e-05 | 4 | 83 | 2 | 17027648 | ||
| Pubmed | 3.37e-05 | 4 | 83 | 2 | 12079992 | ||
| Pubmed | 4.96e-05 | 709 | 83 | 9 | 22988430 | ||
| Pubmed | 5.60e-05 | 5 | 83 | 2 | 29758265 | ||
| Pubmed | 5.60e-05 | 5 | 83 | 2 | 25675294 | ||
| Pubmed | Molecular cloning and characterization of human VPS18, VPS 11, VPS16, and VPS33. | 5.60e-05 | 5 | 83 | 2 | 11250079 | |
| Pubmed | Ubiquitylation and degradation of serum-inducible kinase by hVPS18, a RING-H2 type ubiquitin ligase. | 5.60e-05 | 5 | 83 | 2 | 16203730 | |
| Pubmed | 8.39e-05 | 6 | 83 | 2 | 21802320 | ||
| Pubmed | 8.39e-05 | 6 | 83 | 2 | 23463619 | ||
| Pubmed | 8.39e-05 | 6 | 83 | 2 | 20519450 | ||
| Pubmed | Essential Roles of Intracellular Calcium Release Channels in Muscle, Brain, Metabolism, and Aging. | 8.39e-05 | 6 | 83 | 2 | 25966694 | |
| Pubmed | CORVET, CHEVI and HOPS - multisubunit tethers of the endo-lysosomal system in health and disease. | 8.39e-05 | 6 | 83 | 2 | 31092635 | |
| Pubmed | 8.39e-05 | 6 | 83 | 2 | 16352659 | ||
| Pubmed | 8.39e-05 | 6 | 83 | 2 | 26921097 | ||
| Pubmed | IP3Rs are sufficient for dendritic cell Ca2+ signaling in the absence of RyR1. | 8.39e-05 | 6 | 83 | 2 | 16844763 | |
| Pubmed | 8.39e-05 | 6 | 83 | 2 | 11382755 | ||
| Pubmed | Receptor-mediated clustering of FIP200 bypasses the role of LC3 lipidation in autophagy. | 1.09e-04 | 454 | 83 | 7 | 33226137 | |
| Pubmed | RILP interacts with HOPS complex via VPS41 subunit to regulate endocytic trafficking. | 1.17e-04 | 7 | 83 | 2 | 25445562 | |
| Pubmed | 1.17e-04 | 7 | 83 | 2 | 11860456 | ||
| Pubmed | Large-scale phosphomimetic screening identifies phospho-modulated motif-based protein interactions. | 1.44e-04 | 110 | 83 | 4 | 37219487 | |
| Pubmed | SPE-39 family proteins interact with the HOPS complex and function in lysosomal delivery. | 1.56e-04 | 8 | 83 | 2 | 19109425 | |
| Pubmed | Identification of mouse Vps16 and biochemical characterization of mammalian class C Vps complex. | 1.56e-04 | 8 | 83 | 2 | 14623309 | |
| Pubmed | 1.56e-04 | 8 | 83 | 2 | 25783203 | ||
| Pubmed | Roles of IP3R and RyR Ca2+ channels in endoplasmic reticulum stress and beta-cell death. | 1.56e-04 | 8 | 83 | 2 | 19033399 | |
| Pubmed | Structural basis of Vps33A recruitment to the human HOPS complex by Vps16. | 1.56e-04 | 8 | 83 | 2 | 23901104 | |
| Pubmed | Identification of the switch in early-to-late endosome transition. | 1.56e-04 | 8 | 83 | 2 | 20434987 | |
| Pubmed | The HOPS complex mediates autophagosome-lysosome fusion through interaction with syntaxin 17. | 1.56e-04 | 8 | 83 | 2 | 24554770 | |
| Pubmed | Mammalian CORVET is required for fusion and conversion of distinct early endosome subpopulations. | 2.00e-04 | 9 | 83 | 2 | 25266290 | |
| Pubmed | Modulating Wnt Signaling Rescues Palate Morphogenesis in Pax9 Mutant Mice. | 2.00e-04 | 9 | 83 | 2 | 28692808 | |
| Pubmed | ZC3H14 EEF1G MAN2A1 KMT2B VEZF1 EIF5 CD55 MCM5 ZNF217 TRMT1L EIF4G3 AGRN | 2.21e-04 | 1497 | 83 | 12 | 31527615 | |
| Pubmed | 2.50e-04 | 10 | 83 | 2 | 26463206 | ||
| Pubmed | 2.50e-04 | 10 | 83 | 2 | 18765668 | ||
| Pubmed | HIV-1 gp120 N-linked glycosylation differs between plasma and leukocyte compartments. | 2.50e-04 | 10 | 83 | 2 | 18215327 | |
| Pubmed | 2.50e-04 | 10 | 83 | 2 | 18330979 | ||
| Pubmed | 2.50e-04 | 10 | 83 | 2 | 18314154 | ||
| Pubmed | 2.50e-04 | 10 | 83 | 2 | 18799622 | ||
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | 3.00e-04 | 1105 | 83 | 10 | 35748872 | |
| Pubmed | 3.05e-04 | 11 | 83 | 2 | 18552835 | ||
| Pubmed | 3.05e-04 | 11 | 83 | 2 | 17015619 | ||
| Pubmed | 3.49e-04 | 57 | 83 | 3 | 18022353 | ||
| Pubmed | Activator-mediated recruitment of the MLL2 methyltransferase complex to the beta-globin locus. | 3.66e-04 | 12 | 83 | 2 | 17707229 | |
| Pubmed | 3.66e-04 | 12 | 83 | 2 | 19693543 | ||
| Pubmed | 3.66e-04 | 12 | 83 | 2 | 21411634 | ||
| Pubmed | Insights on ADAMTS proteases and ADAMTS-like proteins from mammalian genetics. | 3.66e-04 | 12 | 83 | 2 | 25770910 | |
| Pubmed | Interaction network of human aminoacyl-tRNA synthetases and subunits of elongation factor 1 complex. | 4.31e-04 | 13 | 83 | 2 | 11829477 | |
| Pubmed | 4.31e-04 | 13 | 83 | 2 | 24550300 | ||
| Pubmed | Complement factor H, a marker of self protects against experimental autoimmune encephalomyelitis. | 5.03e-04 | 14 | 83 | 2 | 19299737 | |
| Pubmed | 5.03e-04 | 418 | 83 | 6 | 34709266 | ||
| Pubmed | 5.79e-04 | 15 | 83 | 2 | 8892864 | ||
| Pubmed | H-2 haplotypes, genes, and antigens: second listing. I. Non-H-2 loci on chromosome 17. | 7.48e-04 | 17 | 83 | 2 | 6816725 | |
| Pubmed | 7.48e-04 | 17 | 83 | 2 | 2355006 | ||
| Pubmed | 7.48e-04 | 17 | 83 | 2 | 14668490 | ||
| Pubmed | 7.48e-04 | 17 | 83 | 2 | 19183483 | ||
| Pubmed | 7.82e-04 | 75 | 83 | 3 | 20637190 | ||
| Pubmed | Functional genomic landscape of cancer-intrinsic evasion of killing by T cells. | 8.01e-04 | 457 | 83 | 6 | 32968282 | |
| Pubmed | Proteolysis of fibrillin-2 microfibrils is essential for normal skeletal development. | 8.40e-04 | 18 | 83 | 2 | 35503090 | |
| Pubmed | 9.37e-04 | 19 | 83 | 2 | 18329113 | ||
| Pubmed | 1.04e-03 | 20 | 83 | 2 | 12560567 | ||
| Pubmed | BRCA1- and BRCA2-Associated Hereditary Breast and Ovarian Cancer | 1.15e-03 | 21 | 83 | 2 | 20301425 | |
| Pubmed | 1.18e-03 | 330 | 83 | 5 | 32529326 | ||
| Pubmed | An approach based on a genome-wide association study reveals candidate loci for narcolepsy. | 1.20e-03 | 193 | 83 | 4 | 20677014 | |
| Pubmed | 1.22e-03 | 332 | 83 | 5 | 37433992 | ||
| Pubmed | 1.26e-03 | 22 | 83 | 2 | 8673525 | ||
| Pubmed | Effect of various glycosidase treatments on the resistance of the HIV-1 envelope to degradation. | 1.26e-03 | 22 | 83 | 2 | 9109416 | |
| Pubmed | Positional cloning of the mouse saccharin preference (Sac) locus. | 1.26e-03 | 22 | 83 | 2 | 11555487 | |
| Pubmed | 1.26e-03 | 22 | 83 | 2 | 11530211 | ||
| Pubmed | 1.26e-03 | 1103 | 83 | 9 | 34189442 | ||
| Pubmed | 1.38e-03 | 23 | 83 | 2 | 1736542 | ||
| Pubmed | 1.38e-03 | 23 | 83 | 2 | 8093218 | ||
| Pubmed | Glycosylation inhibitors block the expression of LAV/HTLV-III (HIV) glycoproteins. | 1.38e-03 | 23 | 83 | 2 | 3099781 | |
| Pubmed | Role of protein N-glycosylation in pathogenesis of human immunodeficiency virus type 1. | 1.38e-03 | 23 | 83 | 2 | 3264072 | |
| Pubmed | Hedgehog signalling controls sinoatrial node development and atrioventricular cushion formation. | 1.50e-03 | 24 | 83 | 2 | 34062094 | |
| Pubmed | Effect of N-(3-phenyl-2-propenyl)-1-deoxynojirimycin on the lectin binding to HIV-1 glycoproteins. | 1.63e-03 | 25 | 83 | 2 | 2283726 | |
| Pubmed | MKRN2 Physically Interacts with GLE1 to Regulate mRNA Export and Zebrafish Retinal Development. | 1.69e-03 | 358 | 83 | 5 | 32460013 | |
| Pubmed | 1.75e-03 | 214 | 83 | 4 | 22199357 | ||
| Pubmed | Transcriptional profiling of sequentially generated septal neuron fates. | 1.76e-03 | 26 | 83 | 2 | 34851821 | |
| Pubmed | Molecular profiles of mitogen activated protein kinase signaling pathways in orofacial development. | 1.76e-03 | 26 | 83 | 2 | 17177285 | |
| Pubmed | 1.76e-03 | 26 | 83 | 2 | 8218172 | ||
| Pubmed | Perlecan regulates pericyte dynamics in the maintenance and repair of the blood-brain barrier. | 1.90e-03 | 27 | 83 | 2 | 31541017 | |
| Pubmed | ATM and ATR substrate analysis reveals extensive protein networks responsive to DNA damage. | 1.90e-03 | 27 | 83 | 2 | 17525332 | |
| Pubmed | 2.04e-03 | 28 | 83 | 2 | 26173459 | ||
| Pubmed | 2.06e-03 | 105 | 83 | 3 | 9628581 | ||
| Pubmed | 2.34e-03 | 30 | 83 | 2 | 12676797 | ||
| Interaction | FAM90A26 interactions | 1.19e-05 | 2 | 70 | 2 | int:FAM90A26 | |
| Cytoband | 8p23.1 | FAM90A14 FAM90A17 FAM90A19 FAM90A22 FAM90A23 FAM90A2P FAM90A7 FAM90A18 FAM90A9 FAM90A8 FAM90A16 FAM90A10 | 1.04e-16 | 154 | 83 | 12 | 8p23.1 |
| Cytoband | Ensembl 112 genes in cytogenetic band chr8p23 | FAM90A14 FAM90A17 FAM90A19 FAM90A22 FAM90A23 FAM90A2P FAM90A7 FAM90A18 FAM90A9 FAM90A8 FAM90A16 FAM90A10 | 1.63e-14 | 234 | 83 | 12 | chr8p23 |
| GeneFamily | Zinc fingers C2H2-type|ZF class homeoboxes and pseudogenes | ZXDC ZNF536 VEZF1 ZNF425 ZSCAN5A FIZ1 PLAG1 ZNF217 ZNF565 ZNF319 ZNF865 ZNF786 | 3.35e-07 | 718 | 49 | 12 | 28 |
| GeneFamily | Mannosidases alpha class 2 | 7.16e-05 | 5 | 49 | 2 | 1194 | |
| GeneFamily | ADAM metallopeptidases with thrombospondin type 1 motif | 1.19e-03 | 19 | 49 | 2 | 50 | |
| GeneFamily | Zinc fingers C2H2-type|Lysine methyltransferases|PR/SET domain family | 3.82e-03 | 34 | 49 | 2 | 487 | |
| Coexpression | GSE19888_CTRL_VS_A3R_INHIBITOR_TREATED_MAST_CELL_DN | 1.63e-05 | 195 | 72 | 6 | M7310 | |
| Coexpression | GSE2770_UNTREATED_VS_TGFB_AND_IL12_TREATED_ACT_CD4_TCELL_48H_UP | 1.88e-05 | 200 | 72 | 6 | M6055 | |
| ToppCell | Control-PLT_4|Control / Disease Group and Platelet Clusters | 8.26e-07 | 198 | 72 | 6 | 387fd3037fd52e4d4c42de0588767e58af228b59 | |
| ToppCell | wk_20-22-Hematologic-Meg-ery-Definitive_erythroblast|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 1.15e-05 | 182 | 72 | 5 | 0c77ef4556c1d1512ebe9077df858b28f9e38dd5 | |
| ToppCell | Control-Stromal_mesenchymal-Lung_smooth_muscle-MatrixFB_->_Myofibroblast|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.18e-05 | 183 | 72 | 5 | 7eae9b3b4d1c9b135fa7cff348393d4adec474b4 | |
| ToppCell | Fibroblasts-CD55+_Fibroblasts|Fibroblasts / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues | 1.42e-05 | 190 | 72 | 5 | b4088128f5acf53f43244c9af9fe44e033f1a57a | |
| ToppCell | human_hepatoblastoma-Tumor_cells|World / Sample and Cell Type and Tumor Cluster (all cells) | 1.49e-05 | 192 | 72 | 5 | 916fbec1c7ab7969bda711886ac88e877e30c280 | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_myocytic-mes_proliferating_SM_(20)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 1.53e-05 | 193 | 72 | 5 | bbdfda6665941cfa1965418bb91ef9ff43b1326f | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_myocytic-mes_proliferating_SM_(20)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 1.57e-05 | 194 | 72 | 5 | 590a9d4f054e6a3685daf752c9354650fcc7d18a | |
| ToppCell | Sepsis-Leuk-UTI-Lymphocyte-T/NK-dn_T|Leuk-UTI / Disease, condition lineage and cell class | 1.77e-05 | 199 | 72 | 5 | aa4d8ce8994e5032a33d5cc68c482882147cdc3b | |
| Disease | dystonia (is_implicated_in) | 4.41e-04 | 14 | 66 | 2 | DOID:543 (is_implicated_in) | |
| Disease | nephroblastoma (is_implicated_in) | 4.41e-04 | 14 | 66 | 2 | DOID:2154 (is_implicated_in) | |
| Disease | visceral:subcutaneous adipose tissue ratio | 5.26e-04 | 70 | 66 | 3 | EFO_0004767 | |
| Disease | BREAST CANCER | 1.01e-03 | 21 | 66 | 2 | 114480 | |
| Disease | Heart valve disease | 1.55e-03 | 26 | 66 | 2 | C0018824 | |
| Disease | Malignant tumor of breast | 1.67e-03 | 27 | 66 | 2 | cv:C0006142 | |
| Disease | Breast neoplasm | 1.67e-03 | 27 | 66 | 2 | cv:C1458155 | |
| Disease | Familial cancer of breast | 1.67e-03 | 27 | 66 | 2 | cv:C0346153 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| FTKDPCPLCDEAKEV | 36 | A6NC05 | |
| CQVRPNPEEKKCFDL | 351 | Q8TDY4 | |
| CPEGPKCQFAQKIRE | 156 | A6NMK7 | |
| KLLNENPFKCEDPCE | 636 | Q5JQC9 | |
| CGFKNSQPLPCERKD | 531 | Q9Y3Q7 | |
| QENVFKKFDGPCDPC | 306 | O00468 | |
| SKCQGAERCDPELPK | 576 | Q9Y6B7 | |
| DCPVCLPLKNASDKR | 426 | Q92793 | |
| CKCSFNQKPRAPGDE | 61 | Q9H0Q3 | |
| KQFDPFCPLKSVDCL | 1236 | Q6DHV5 | |
| KPCCACPETKKARDA | 21 | Q14061 | |
| DEEDPRLKCKNCGAF | 36 | A6NDY2 | |
| PEECKDVNKVAYCPL | 1066 | Q9H324 | |
| ACNTNFCPAPEKRED | 1171 | Q8TE60 | |
| DEEDPRLKCKNCGAF | 36 | A6NKC0 | |
| AAGDLDNPPKKFRDC | 41 | Q14573 | |
| DNPPKKFRDCLFKVC | 46 | Q14573 | |
| SFCTQKPRKFDCELP | 561 | Q8TDY2 | |
| DEEDPRLKCKNCGAF | 36 | A8MXZ1 | |
| PFCELDVNKCKISPC | 961 | Q5T1H1 | |
| GPDPKICCQFDFKRL | 361 | Q16706 | |
| KCNTDQAGRPKCPLD | 196 | P33992 | |
| INHDCKPNCKFVPAD | 181 | Q86Y97 | |
| DEEDPRLKCKNCEAF | 36 | Q86YD7 | |
| KKEQENNFDPACCPA | 536 | Q5HYC2 | |
| PDPSDFDRCCKLKDR | 46 | Q53QV2 | |
| EFCKKKSCPNPGEIR | 156 | P08174 | |
| DEEDPRLKCKNCGAF | 36 | A8MWA6 | |
| DEEDPRLKCKNCGAF | 36 | P0C7W9 | |
| KKPPEESTCFERPCF | 841 | Q86TH1 | |
| KFPIEDASNKLPCNC | 2691 | Q9UMN6 | |
| DEEDPRLKCKNCGAF | 36 | P0DV74 | |
| ICKEFSLPPCVDEKD | 171 | Q14990 | |
| DEEDPRLKCKNCGAF | 36 | P0DV73 | |
| KEKERPPSCCAAAGA | 151 | Q9UPP2 | |
| DEEDPRLKCKNCGAF | 36 | P0DV76 | |
| DFGFDLPDCKARKQP | 611 | O15350 | |
| DEEDPRLKCKNCGAF | 36 | A6NJQ4 | |
| CLPSNEDKEEFPLCA | 81 | Q96EF6 | |
| CPNKEKECQPPFAFR | 191 | P05107 | |
| KDCNPAKPEKLANRC | 831 | O60308 | |
| AKPEKLANRCPLCHE | 836 | O60308 | |
| GFIKKFVLCPECENP | 91 | P55010 | |
| CAFPKEFANRCLSPE | 2636 | P51587 | |
| KFCLQPRDEKPFCAT | 51 | Q9UBT3 | |
| KPPNCKAFRDEELCK | 611 | Q5VV63 | |
| KPFKCPRCERDFNAP | 226 | Q96SL8 | |
| GPDPKICCQFDFKRL | 361 | P49641 | |
| KLVPFSKDCGPDNEC | 781 | O75578 | |
| KCDLKPCPNTVDCFI | 156 | Q6PEY0 | |
| CEQALAAEPKAKDPF | 266 | P26641 | |
| DEEDPRLKCKNCGAF | 36 | A6NIJ5 | |
| DEEDPRLKCKNCGAF | 36 | A8MXJ8 | |
| LLNFKDDKSECPCPE | 1976 | Q92736 | |
| CPICKERFPAESDKD | 656 | Q9P1Z2 | |
| LPTNENDDDICKKPC | 326 | O43432 | |
| NDDDICKKPCSVAPN | 331 | O43432 | |
| DEEDPRLKCKNCGAF | 36 | P0C7X0 | |
| LKCFEPDPDKRACAN | 916 | Q99683 | |
| EDPPCKCPNKFCVER | 211 | O43903 | |
| QRCKKCPQPLFEDPE | 91 | Q9BQQ7 | |
| APKKLCDPFGSCDAR | 271 | Q8N1G1 | |
| GNRQACPLCPKEKFR | 116 | Q7Z2T5 | |
| DKIREDCCPGKPLNV | 1046 | Q9P2J5 | |
| DEEDPRLKCKNCGAF | 36 | A8MX19 | |
| DEEDPRLKCKNCGAF | 36 | A6NNJ1 | |
| DEEDPRLKCKNCGAF | 36 | P0C7W8 | |
| DEEDPRLKCKNCGAF | 36 | D6RGX4 | |
| FKLAPPLDCVEGKNC | 426 | Q9NZ20 | |
| DEEDPRLKCKNCGAF | 36 | P0C7V4 | |
| ELKPLECCEFPFGSK | 106 | O15198 | |
| FKAQLFCCKAERPEP | 341 | P32247 | |
| KKCPPQRLARFEEEC | 281 | Q9Y4C5 | |
| GETKPRKNFPCQLCD | 26 | Q6DJT9 | |
| PDEELPCSARNCKKD | 471 | P35443 | |
| CPDLESRCEKFLQKD | 116 | Q8N9K5 | |
| RPELRCPACLKAFKD | 986 | P0CJ78 | |
| RCPEPQCALAFAKKH | 176 | Q2QGD7 | |
| PFECPICNQRFKRKD | 201 | Q14119 | |
| DDIKPCPRCAAYIIK | 296 | Q9NV58 | |
| DKCATCDFPLLNRPF | 851 | Q9P253 | |
| KEKLCEFNCNIRAPP | 251 | Q9H269 | |
| DEEDPRLKCKNCRAL | 36 | Q658T7 | |
| KALPPFACDVCEKRF | 351 | Q9BUG6 | |
| EDDARKNRKYPCPLC | 121 | O15090 | |
| ERPFHCPECDKNFRE | 701 | Q8N393 | |
| AREKPLKCPDCEKRF | 481 | Q9P2F9 | |
| EPPKEKNCKENEFSC | 116 | O75362 | |
| EQKPFPCAECGKRFT | 466 | Q6IV72 | |
| PCKAFPNCKFAEKCL | 621 | Q6PJT7 | |
| CPLEVAAAPKLCKEF | 21 | Q49AM3 | |
| DEEDPRLKCKNCGAF | 36 | P0DV75 | |
| CCDLDPEKRPSFVKL | 586 | P53667 |